Sign in
4

Changes in Ownership

Renalytix plc Filed Acc 0001209191-23-041799

Options or other derivatives

  • Chief Executive Officer acquired 875,017 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McCullough James Renwick · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-06 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +875,017 875,017 D
Loading xslF345X04/doc4.xml…